Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Id-KLH Primed Autologous Lymphocytes in Multiple Myeloma Post-Transplant
NCT01426828Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Aug 2011
- Primary completion
- Jun 2016
- Countries
- 1
01
Overview
A Phase 2 trial of FavId in multiple myeloma (MM), sponsored by University of Pennsylvania. Started Aug 2011; status: completed.
02
Drugs
FavId
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01426828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01426828.